ResearcherUniversity of LouisvilleActive in the last 2 years
Prejesh Philips
Matched on OpenAlex author ID A5113899159. Sources: ClinicalTrials.gov.
Their work
- Papers
- 12 (first author 1, last author 2)
- Trials
- 1 (principal investigator on 1)
- Grants
- 0
- Labs led
- 1
- Collaborators
- 7
2014: 1 paper, 1 trial · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 4 papers · 2025: 1 paper · 2026: 1 paper
Papers 12
- Evaluation of radiomics and radiologic signatures for diagnosis and clinical outcomes in pancreatic adenocarcinoma and pancreatic neuroendocrine: A pilot study. Last author DOI 10.1177/18758592261455545↗
- Detection of Exhaled Volatile Organic Compounds as Noninvasive Biomarkers for Pancreatic Adenocarcinoma. Co-author DOI 10.1245/s10434-025-17685-z↗
- Barriers to resection following neoadjuvant chemotherapy for resectable pancreatic adenocarcinoma: A national and local perspective. Co-author DOI 10.1002/jso.27697↗
- Multi-institutional review of adverse events associated with irreversible electroporation in the treatment of locally advanced pancreatic cancer. First author DOI 10.1016/j.surg.2023.08.042↗
- Diagnosis of Pancreatic Cancer after Cholecystectomy in the Elderly. Co-author DOI 10.1177/00031348241227165↗
- Optimization of Exocrine Pancreatic Insufficiency in Pancreatic Adenocarcinoma Patients. Co-author DOI 10.3390/nu16203499↗
- Impact of margin accentuation with intraoperative irreversible electroporation on local recurrence in resected pancreatic cancer. Co-author DOI 10.1016/j.surg.2022.07.033↗
- Locally advanced pancreatic cancer: a reliable contraindication to resection in the modern era? Co-author DOI 10.1016/j.hpb.2021.09.002↗
- An Improved Staging System for Locally Advanced Pancreatic Cancer: A Critical Need in the Multidisciplinary Era. Co-author DOI 10.1245/s10434-021-10174-z↗
- Efficacy of preoperative immunonutrition in locally advanced pancreatic cancer undergoing irreversible electroporation (IRE). Last author DOI 10.1016/j.ejso.2017.01.002↗
- Efficacy of irreversible electroporation in human pancreatic adenocarcinoma: advanced murine model. Co-author DOI 10.1038/mtm.2015.1↗
- The role of hepatic artery lymph node in pancreatic adenocarcinoma: prognostic factor or a selection criterion for surgery. Co-author DOI 10.1111/hpb.12306↗
Trials 1
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Robert C.G. Martin · 12 shared papers, 2014–2026 · strength 2.25
- Paper Evaluation of radiomics and radiologic signatures for diagnosis and clinical outcomes in pancreatic adenocarcinoma and … DOI 10.1177/18758592261455545↗
- Paper Optimization of Exocrine Pancreatic Insufficiency in Pancreatic Adenocarcinoma Patients. DOI 10.3390/nu16203499↗
- Paper Multi-institutional review of adverse events associated with irreversible electroporation in the treatment of locally a… DOI 10.1016/j.surg.2023.08.042↗
- Charles Raben Scoggins · 11 shared papers, 2014–2026 · strength 2.18
- Paper Evaluation of radiomics and radiologic signatures for diagnosis and clinical outcomes in pancreatic adenocarcinoma and … DOI 10.1177/18758592261455545↗
- Paper Optimization of Exocrine Pancreatic Insufficiency in Pancreatic Adenocarcinoma Patients. DOI 10.3390/nu16203499↗
- Paper Multi-institutional review of adverse events associated with irreversible electroporation in the treatment of locally a… DOI 10.1016/j.surg.2023.08.042↗
- Michael E. Egger · 9 shared papers, 2021–2026 · strength 2.05
- Paper Evaluation of radiomics and radiologic signatures for diagnosis and clinical outcomes in pancreatic adenocarcinoma and … DOI 10.1177/18758592261455545↗
- Paper Optimization of Exocrine Pancreatic Insufficiency in Pancreatic Adenocarcinoma Patients. DOI 10.3390/nu16203499↗
- Paper Multi-institutional review of adverse events associated with irreversible electroporation in the treatment of locally a… DOI 10.1016/j.surg.2023.08.042↗
- Marc W. Fromer · 5 shared papers, 2021–2026 · strength 1.08
- Paper Evaluation of radiomics and radiologic signatures for diagnosis and clinical outcomes in pancreatic adenocarcinoma and … DOI 10.1177/18758592261455545↗
- Paper Barriers to resection following neoadjuvant chemotherapy for resectable pancreatic adenocarcinoma: A national and local… DOI 10.1002/jso.27697↗
- Paper Diagnosis of Pancreatic Cancer after Cholecystectomy in the Elderly. DOI 10.1177/00031348241227165↗
- Kyle R Stephens · 2 shared papers, 2024–2025 · strength 0.47
- Paper Multi-institutional review of adverse events associated with irreversible electroporation in the treatment of locally a… DOI 10.1016/j.surg.2023.08.042↗
- Paper Detection of Exhaled Volatile Organic Compounds as Noninvasive Biomarkers for Pancreatic Adenocarcinoma. DOI 10.1245/s10434-025-17685-z↗
- Jacob W. H. Gordon · 1 shared paper, 2026 · strength 0.33
- Jaclyn V. Moore · 1 shared paper, 2024 · strength 0.28
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.